Search results
Two years later, over-the-counter hearing aids are still finding their groove
Digital Trends via Yahoo News· 7 hours agoSennheiser It’s been a little less than two years since the Food and Drug Administration formally...
Heat Rash Remedies: At-Home Treatment, Self-Care, and OTC Options
Verywell Health via Yahoo News· 6 hours agoThere are many heat rash remedies you can use to treat the rash at home, including natural home...
What is the best medicine for back pain?
Medical News Today· 2 days agoResearchers have conducted several research reviews into medications for back pain. Back pain is a common condition with many possible causes. People can...
Anticholinergic Medications
Health via Yahoo News· 6 days agoAsk your pharmacist or healthcare provider if you are unsure whether any of your prescription or over-the-counter (OTC) drugs are anticholinergics....
Opinion | Narcan May Have Moved Over-the-Counter, but It’s Still Underutilized
MedPage Today· 2 days agoThis is just one of the commercials you might have seen or heard for over-the-counter (OTC) naloxone...
Governor Gavin Newsom Says, “California is Disrupting the Drug Industry with CalRx” as the State...
Sierra Sun Times· 3 days agoWHAT YOU NEED TO KNOW: California, disrupting the drug industry through CalRx®, is now set to...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Benzinga via Yahoo Finance· 2 days agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on...
Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans
Digital Journal· 2 days agoThis plan includes a wider pilot study demographic of thirty (30) participants, followed by...
... ETFs Surge As DEA Moves To Reschedule Marijuana - Aurora Cannabis (NASDAQ:ACB), Cannabist...
Benzinga· 2 days agoThe cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement...
RIV Capital Applauds Reports that DEA Plans to Reschedule Cannabis
FOX40 Sacramento· 1 day agoRIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and...